TRILLIUM THERAPEUTICS INC. Proceeds from Stock Options Exercised
TRILLIUM THERAPEUTICS INC. reported Proceeds from Stock Options Exercised of $2.21 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-12.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2021-11-12
- TRILLIUM THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2021-09-30 was $112.00K, a 70.68% decline year-over-year.
- TRILLIUM THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2021-06-30 was $473.00K, a 2682.35% increase year-over-year.
- TRILLIUM THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2021-03-31 was $1.62M, a 50.37% increase year-over-year.
- TRILLIUM THERAPEUTICS INC. proceeds from stock options exercised for the quarter ending 2020-12-31 was $3.02M.
- TRILLIUM THERAPEUTICS INC. proceeds from stock options exercised for fiscal 2020 was $4.50M.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2021-09-30 | $112.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $585.00K derived: sum of 2 quarters · filed 2021-11-12 | $2.21M 10-Q · filed 2021-11-12 | $5.22M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-06-30 | $473.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $2.09M 10-Q · filed 2021-08-13 | $5.11M derived: sum of 3 quarters · filed 2021-08-13 | $5.49M derived: sum of 4 quarters · filed 2021-11-12 |
| 2021-03-31 | $1.62M 10-Q · filed 2021-05-07 | $4.64M derived: sum of 2 quarters · filed 2021-05-07 | $5.02M derived: sum of 3 quarters · filed 2021-11-12 | $5.04M derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $3.40M derived: sum of 2 quarters · filed 2021-11-12 | $3.42M derived: sum of 3 quarters · filed 2021-11-12 | $4.50M 10-K · filed 2021-03-18 |
| 2020-09-30 | $382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $399.00K derived: sum of 2 quarters · filed 2021-11-12 | $1.48M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $1.09M 10-Q · filed 2021-08-13 | ||
| 2020-03-31 | $1.08M 10-Q · filed 2021-05-07 |